Ignyta
develops and commercializes targeted molecule therapies for the treatment of cancer... Read moreIgnyta
develops and commercializes targeted molecule therapies for the treatment of cancer... Read more
2011
Out Of Business
Add Sector
News
Aug 09, 2019
BioCentury
Ignyta: ORIC raises $55M to fund trials in drug-resistant cancers
Nov 15, 2018
BioPortfolio
Ignyta: Ignyta Inc Medical Equipment Deals and Alliances Profile Report Updated 23102018 Prices from USD $250
Sep 25, 2018
The Pharma Letter
Ignyta: Roche plans regulatory filings for promising lung cancer candidate
Aug 17, 2018
BioPortfolio
Ignyta: Ignyta Inc RXDX Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Apr 14, 2018
BioPortfolio
Ignyta: Ignyta Inc RXDX Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250
Feb 08, 2018
Reuters
Ignyta: BRIEF-Roche gets shares in Ignyta tender offer
Jan 16, 2018
FinanzNachrichten
Ignyta: ACT NOW: Monteverde & Associates PC Announces An Investigation of Ignyta, Inc. - RXDX
Jan 04, 2018
PharmiWeb
Ignyta: Ignyta to Present at 36th Annual J.P. Morgan Healthcare Conference
Jan 03, 2018
4-traders
Ignyta: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Ignyta, Inc. to Roche Holding AG is Fair to Shareholders
Jan 02, 2018
PharmaTimes
Ignyta: Roche to buy Ignyta for $1.7 billion